Kynam Capital Management’s Sanofi SNY Stock Holding History

Kynam Capital Management’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-600,000	Closed	-$22.8M	–	38
2022 Q3	$22.8M	Buy	+600,000	New	+$26.7M	4.81%	6

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Kynam Capital Management's SNY Position: Q4 2022 in Review

Kynam Capital Management sold out of Sanofi (SNY) in Q4 2022, closing a stake of 600,000 shares — an estimated $22.8M sold.

Kynam Capital Management first reported a position in SNY in Q3 2022 and held it in 1 quarter. The position peaked at $22.8M in Q3 2022. 643 funds tracked by Wall St. Rank hold SNY as of Q4 2022.

Kynam Capital Management reported no remaining Sanofi position as of Q4 2022 after selling out during the quarter.
Kynam Capital Management sold 600,000 Sanofi shares in Q4 2022, an estimated $22.8M.
Kynam Capital Management first reported a position in Sanofi in Q3 2022 and held it in 1 quarter.
Kynam Capital Management's Sanofi position peaked at $22.8M in Q3 2022.
643 funds tracked by Wall St. Rank held Sanofi as of Q4 2022.

Based on Kynam Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.